Aquestive Therapeutics Cash Flow Statement (2017-2026) | AQST

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-12.37M	-14.55M	-28.95M	-13.22M	-16.30M	-12.54M	-12.35M	8.07M	-5.79M	-2.04M	-8.11M	-12.83M	-2.75M	-11.51M	-17.05M	-22.93M	-13.55M	-15.45M	-31.86M	-8.06M
Depreciation and Depletion (Quarter)	0.73M	0.72M	0.72M	0.71M	0.66M	0.56M	0.34M	0.29M	0.25M	0.22M	0.39M	0.17M	0.17M	0.16M	0.15M	0.14M	0.14M	0.14M	0.13M	0.11M
Share-based Compensation (Quarter)	1.72M	1.90M	1.69M	0.91M	2.22M	0.54M	0.71M	0.34M	0.63M	0.77M	0.94M	1.58M	1.54M	1.58M	2.40M	1.59M	1.88M	2.78M	1.38M	2.32M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	0.17M	0.01M	0.00M	0.10M	0.06M	-0.16M	0.05M	0.01M	0.00M	-0.01M		0.89M	0.01M	0.20M	0.00M	-0.05M	0.05M	0.79M	-0.79M	0.33M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-1.76M	-9.06M	-8.06M	-14.48M	-6.56M	2.81M	8.42M	8.82M	-7.91M	-2.35M	-4.94M	-10.38M	-7.01M	-11.88M	-6.49M	-23.40M	-7.91M	-12.65M	-8.47M	-14.81M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)	1.17M	1.17M	0.13M	0.04M	0.00M	0.00M	0.06M	0.06M	0.00M	0.00M	1.80M	2.67M	2.67M	2.67M	-7.78M	2.75M	2.75M	-5.32M	0.06M	0.06M
Depreciation & Amortization (CF) (Quarter)	0.74M	0.74M	0.73M	0.73M	0.67M	0.60M	0.40M	0.33M	0.29M	0.26M	0.47M	0.21M	0.20M	0.16M	0.15M	0.14M	0.14M	0.14M	0.13M	0.11M
Change in Working Capital
Change in Receivables (Quarter)	2.02M	1.33M	-1.37M	7.68M	-0.73M	-8.21M	-6.09M	2.22M	2.51M	-1.55M	-0.10M	-0.15M	-2.34M	3.71M	-2.32M	3.13M	1.35M	-0.06M	5.96M	-10.90M
Change in Inventory (Quarter)	0.04M	0.02M	1.18M	0.59M	0.38M	1.72M	-0.94M	1.20M	-1.03M	1.13M	-0.31M	0.96M	-0.77M	0.06M	-0.98M	1.15M	0.93M	-0.24M	-1.71M	1.90M
Change in Account Payables (Quarter)	1.41M	-1.89M	2.10M	0.18M	0.39M	2.18M	-1.12M	2.49M	-1.75M	-0.69M	-1.07M	1.28M	-3.01M	1.88M	2.64M	1.91M	-0.32M	-1.31M	19.25M	-17.97M
Change in Accured Expenses (Quarter)	-0.47M	0.93M	1.20M	-3.96M	1.94M	-0.34M	-0.03M	-3.47M	-1.17M	1.17M	0.95M	-1.87M	0.13M	-0.66M	0.92M	-2.78M	0.60M	0.12M	5.09M	-2.80M
Other Working Capital Changes (Quarter)	-3.07M	6.29M	-5.01M	0.23M	6.97M	3.31M	14.53M	4.87M	-0.69M	-5.40M	-0.07M	0.25M	-2.12M	0.79M	-11.76M	-0.26M	0.23M	-1.23M	-0.27M	-0.27M
Investing Activities
Capital Expenditures (Quarter)	0.19M	0.08M	0.53M	0.10M	0.68M	0.22M	0.03M	0.00M	0.83M	0.15M	0.02M	0.03M	-0.03M	0.14M	0.01M	0.14M	-0.05M	0.39M	0.09M	0.05M
Cash from Investing Activities (Quarter)	-0.19M	-0.08M	-0.53M	-0.10M	-0.68M	-1.72M	-0.03M	-0.00M	-0.83M	-0.15M	-0.02M	-0.03M	-0.04M	-0.08M	-0.01M	-0.14M	-0.11M	-0.23M	-0.09M	-0.05M
Financing Activities
Other financing activities (Quarter)								9.09M	3.46M	0.01M	-7.91M	0.01M	0.01M	0.01M	-0.02M	0.01M	0.01M	0.01M
Cash from Financing Activities (Quarter)	8.69M	6.08M	5.45M	1.30M	10.20M	-0.14M	0.23M	-9.21M	4.29M	4.98M	3.91M	81.74M	1.71M	-0.02M	0.16M	20.65M	-0.10M	81.41M	0.66M	4.42M
Additional items
Change in Cash (Quarter)	6.74M	-3.07M	-3.14M	-13.29M	2.96M	0.95M	8.62M	-0.39M	-4.45M	2.48M	-1.04M	71.33M	-5.33M	-11.98M	-6.35M	-2.89M	-8.12M	68.53M	-7.89M	-10.44M
Free Cash Flow (Quarter)	-1.95M	-9.15M	-8.59M	-14.59M	-7.24M	2.59M	8.39M	8.81M	-8.73M	-2.50M	-4.96M	-10.41M	-6.98M	-12.02M	-6.50M	-23.54M	-7.86M	-13.04M	-8.55M	-14.86M
Net Cash Flow (Quarter)	6.74M	-3.07M	-3.14M	-13.29M	2.96M	0.95M	8.62M	-0.39M	-4.45M	2.48M	-1.04M	71.33M	-5.33M	-11.98M	-6.35M	-2.89M	-8.12M	68.53M	-7.89M	-10.44M

Research Tools

Aquestive Therapeutics Cash Flow Statement (2017-2026) | AQST

Create an account

Sign In

Reset Password